The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation
Open accessPublished version of a preprint
Abstract
Many types of cancer cells require a supply of fatty acids (FA) for growth and survival, and interrupting de novo FA synthesis in model systems causes potent anticancer effects. We hypothesized that, in addition to synthesis, cancer cells may obtain preformed, diet-derived FA by uptake from the bloodstream. This would require hydrolytic release of FA from triglyceride in circulating lipoprotein particles by the secreted enzyme lipoprotein lipase (LPL), and the expression of CD36, the channel for cellular FA uptake. We find that selected breast cancer and sarcoma cells express and secrete active LPL, and all express CD36. We further show that LPL, in the presence of triglyceride-rich lipoproteins, accelerates the growth of these cells. Providing LPL to prostate cancer cells, which express low levels of the enzyme, did not augment growth, but did prevent the cytotoxic effect of FA synthesis inhibition. Moreover, LPL knockdown inhibited HeLa cell growth. In contrast to the cell lines, immunohistochemical analysis confirmed the presence of LPL and CD36 in the majority of breast, liposarcoma, and prostate tumor tissues examined (n = 181). These findings suggest that, in addition to de novo lipogenesis, cancer cells can use LPL and CD36 to acquire FA from the circulation by lipolysis, and this can fuel their growth. Interfering with dietary fat intake, lipolysis, and/or FA uptake will be necessary to target the requirement of cancer cells for FA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An elevated expression of lipoprotein lipase (LPL) and monoacylglycerol lipase (MAGL) across diverse cancer subtypes and correlates with invasiveness”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Kuemmerle et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,629
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Research works printed but not linked: 2
- Weiss, 1986, Fatty-acid biosynthesis in man, a pathway of minor importance, J Biol Chem, 367, 905
- Parlo, 1984, Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria, J Biol Chem, 259.
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 667
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 659
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Ackerman, D., & Simon, M. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.001 · Cited by 510
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
Zaidi, N., Lupien, L. E., Kuemmerle, N. B., Kinlaw, W. B., Swinnen, J. V., & Smans, K. A. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.08.005 · Cited by 480
Lipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 486
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.84 · Cited by 446
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
Lengyel, E. R., Makowski, L., DiGiovanni, J., & Kolonin, M. G. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.004 · Cited by 436
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Liu, Q., Luo, Q., Halim, A., & Song, G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.002 · Cited by 381
Lipid metabolism in cancer cells under metabolic stress
Munir, R., Lisec, J., Swinnen, J. V., & Zaidi, N. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0451-4 · Cited by 382
Biochemistry and pathophysiology of intravascular and intracellular lipolysisPreprint
Young, S. G., & Zechner, R. (2013) · Genes & Development · doi:10.1101/gad.209296.112 · Cited by 367
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
Watt, M. J., Clark, A. K., Selth, L. A., Haynes, V. R., Lister, N. L., Rebello, R. J., Porter, L. H., Niranjan, B., Whitby, S., Lo, J. C. Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5758 · Cited by 332
Lipid metabolism and lipophagy in cancer
Maan, M., Peters, J. M., Dutta, M., & Patterson, A. D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.097 · Cited by 282
Metabolic reprogramming in triple-negative breast cancer
Wang, Z., Jiang, Q., & Dong, C. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0210 · Cited by 248
“TNBC exhibits enhanced lipid uptake by secreting lipoprotein lipase (LPL, which hydrolyzes the triglycerides in lipoproteins into fatty acids) and expressing CD36 (the channel for cellular fatty acid uptake) 83 .”
BackgroundMetabolic reprogramming in triple-negative breast cancer
Sun, X., Wang, M., Wang, M., Yu, X., Guo, J., Sun, T., Li, X., Yao, L., Dong, H., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00428 · Cited by 243
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
Pan, J., Fan, Z., Wang, Z., Dai, Q., Xiang, Z., Yuan, F., Yan, M., Zhu, Z., Liu, B., & Li, C. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1049-7 · Cited by 244
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Fernández, L. P., de Cedrón, M. G., & de Molina, A. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577420 · Cited by 234
Fatty acid metabolism in breast cancer subtypes
Monaco, M. E. (2017) · Oncotarget · doi:10.18632/oncotarget.15494 · Cited by 216
Feng, W. W., Wilkins, O. M., Bang, S., Ung, M. H., Li, J., An, J., del Genio, C. L., Canfield, K., DiRenzo, J., Wells, W. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.008 · Cited by 214
Lipid metabolism in prostate cancer.
Wu, X., Daniels, G., Lee, P., & Monaco, M. E. (2014) · PubMed Central · Cited by 204
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M. M., Helm, M., Shrestha, R. K., Moldovan, M. V., Don, A. S., et al. (2020) · eLife · doi:10.7554/elife.54166 · Cited by 199
Nath, A., & Chan, C. (2016) · Scientific Reports · doi:10.1038/srep18669 · Cited by 202
Exogenous lipids promote the growth of breast cancer cells via CD36
Zhao, J., Zheng, Z. P., Wang, C., Xing, H., Song, G., Yu, X., Zhu, Y., Wang, X., Zhang, X., & Di, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5864 · Cited by 191
Palmitic acid is an intracellular signaling molecule involved in disease development
Fatima, S., Hu, X., Gong, R., Huang, C., Chen, M., Wong, H. L. X., Bian, Z., & Kwan, H. Y. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03092-7 · Cited by 171
Louie, S. M., Roberts, L. S., Mulvihill, M. M., Luo, K., & Nomura, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.008 · Cited by 154
Lipid accumulation and oxidation in glioblastoma multiforme
Taïb, B., Aboussalah, A. M., Moniruzzaman, M., Chen, S., Haughey, N. J., Kim, S. F., & Ahima, R. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-55985-z · Cited by 153
Mondal, S., Roy, D., Bhattacharya, S. S., Jin, L., Jung, D., Zhang, S., Kalogera, E., Staub, J. K., Wang, Y., Xuyang, W., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31868 · Cited by 154
Exogenous Fatty Acids Are the Preferred Source of Membrane Lipids in Proliferating Fibroblasts
Yao, C.-H., Fowle-Grider, R., Mahieu, N. G., Liu, G., Chen, Y., Wang, R., Singh, M., Potter, G. S., Gross, R. W., Schaefer, J., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.03.007 · Cited by 142
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 147
Robey, R. B., Weisz, J., Kuemmerle, N. B., Salzberg, A. C., Berg, A. S., Brown, D. G., Maurer, L. L., Palorini, R., Al‐Mulla, F., Al-Temaimi, R. A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv037 · Cited by 143
Agostini, M., Almeida, L. Y., Bastos, D. C., Ortega, R. M., Moreira, F. S., Seguin, F., Zecchin, K. G., Raposo, H. F., Oliveira, H. C. F., Amoêdo, N. D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1136 · Cited by 131
Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer
Benjamin, D. I., Cravatt, B. F., & Nomura, D. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.013 · Cited by 131
Role of Mitochondria-Associated ER Membranes in Calcium Regulation in Cancer-Specific Settings
Morciano, G., Marchi, S., Morganti, C., Sbano, L., Bittremieux, M., Kerkhofs, M., Corricelli, M., Danese, A., Karkucińska‐Więckowska, A., Wieckowski, M. R., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.005 · Cited by 136
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy
Zhang, S., Lv, K., Liu, Z., Zhao, R., & Li, F. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01807-9 · Cited by 141
Androgen control of lipid metabolism in prostate cancer: novel insights and future applications
Butler, L. M., Centenera, M. M., & Swinnen, J. V. (2016) · Endocrine Related Cancer · doi:10.1530/erc-15-0556 · Cited by 127
Daniëls, V. W., Smans, K. A., Royaux, I. E., Chypre, M., Swinnen, J. V., & Zaidi, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106913 · Cited by 119
Chereda, H., Bleckmann, A., Menck, K., Perera‐Bel, J., Stegmaier, P., Auer, F., Krämer, F., Leha, A., & Beißbarth, T. (2021) · Genome Medicine · doi:10.1186/s13073-021-00845-7 · Cited by 124
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126
Key Molecules of Fatty Acid Metabolism in Gastric Cancer
Li, C., Zhang, L., Qiu, Z., Deng, W., & Wang, W. (2022) · Biomolecules · doi:10.3390/biom12050706 · Cited by 119
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How
Bröer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176156 · Cited by 116
Li, L., Che, L., Tharp, K. M., Park, H., Pilo, M. G., Cao, D., Cigliano, A., Latte, G., Xu, Z., Ribback, S., et al. (2016) · Hepatology · doi:10.1002/hep.28508 · Cited by 105
Zheng, Y., Zhou, R., Cai, J., Yang, N., Wen, Z., Zhang, Z., Sun, H., Huang, G., Guan, Y., Huang, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0025 · Cited by 105
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wang, W., Bai, L., Li, W., & Cui, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605154 · Cited by 106
Ma, Y., Zha, J., Yang, X., Li, Q., Zhang, Q., Yin, A., Beharry, Z. M., Huang, H., Huang, J., Bartlett, M. G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01667-y · Cited by 109
Ruze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 111
Tumor-Induced Hyperlipidemia Contributes to Tumor Growth
Huang, J., Li, L., Lian, J., Schauer, S., Vesely, P. W., Kratky, D., Höefler, G., & Lehner, R. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.020 · Cited by 103
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target
Feng, W. W., Zuppe, H. T., & Kurokawa, M. (2023) · Cells · doi:10.3390/cells12121605 · Cited by 104
Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem
Schwaiger-Haber, M., Stancliffe, E., Anbukumar, D. S., Sells, B. E., Yi, J., Cho, K., Adkins-Travis, K., Chheda, M. G., Shriver, L. P., & Patti, G. J. (2023) · Nature Communications · doi:10.1038/s41467-023-38403-x · Cited by 98
Mitochondrial and metabolic alterations in cancer cells
Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 97
Huang, J., Mondul, A. M., Weinstein, S. J., Koutros, S., Derkach, A., Karoly, E. D., Sampson, J. N., Moore, S. C., Berndt, S. I., & Albanes, D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.305 · Cited by 88
Tousignant, K. D., Rockstroh, A., Fard, A. T., Lehman, M., Wang, C., McPherson, S. J., Philp, L., Bartoniček, N., Dinger, M. E., Nelson, C. C., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1147 · Cited by 85
Obesity and prostate cancer — microenvironmental roles of adipose tissue
Saha, A., Kolonin, M. G., & DiGiovanni, J. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00764-9 · Cited by 88
Angerer, T. B., Magnusson, Y., Landberg, G., & Fletcher, J. S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03884 · Cited by 89
Enciu, A., Radu, E., Popescu, I. D., Hinescu, M. E., & Ceafalan, L. C. (2018) · BioMed Research International · doi:10.1155/2018/7801202 · Cited by 84
The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective
Simões, I. C. M., Morciano, G., Lebiedzińska, M., Aguiari, G., Pinton, P., Potes, Y., & Wieckowski, M. R. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165834 · Cited by 84
Polyunsaturated fatty acid metabolism in prostate cancer
Berquin, I. M., Edwards, I. J., Kridel, S. J., & Chen, Y. Q. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9299-7 · Cited by 81
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_3 · Cited by 80
Xu, J., Yu, T., Zois, C. E., Cheng, J., Tang, Y., Harris, A. L., & Huang, W. E. (2021) · Cancers · doi:10.3390/cancers13071718 · Cited by 78
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 77
Fatty acid metabolism and cancer development
Chen, Y., & Li, P. (2016) · 中国科学通报:英文版 · doi:10.1007/s11434-016-1129-4 · Cited by 73
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 78
Clinical lipidomics in understanding of lung cancer: Opportunity and challenge
Zhang, L., Zhu, B., Zeng, Y., Shen, H., Zhang, J., & Wang, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.014 · Cited by 70
Endothelial cell metabolism and implications for cancer therapy
Harjes, U., Bensaad, K., & Harris, A. L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.398 · Cited by 72
Metabolic signatures of human breast cancer
Mishra, P., & Ambs, S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.992217 · Cited by 70
Cao, D., Song, X., Che, L., Li, X.-L., Pilo, M., Vidili, G., Porcu, A., Solinas, A., Cigliano, A., Pes, G., et al. (2016) · Liver international (Print) · doi:10.1111/liv.13183 · Cited by 72
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic OpportunitiesPreprint
Zadra, G., & Loda, M. F. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030569 · Cited by 65
Milk fat components with potential anticancer activity—a review
Rodríguez-Alcalá, L. M., Castro-Gómez, M. P., Pimentel, L. L., & Fontecha, J. (2017) · Bioscience Reports · doi:10.1042/bsr20170705 · Cited by 72
Pathophysiology of Lipid Droplets in Neuroglia
Smolič, T., Zorec, R., & Vardjan, N. (2021) · Antioxidants · doi:10.3390/antiox11010022 · Cited by 71
Larkin, J. R., Anthony, S., Johanssen, V. A., Yeo, T., Sealey, M. A., Yates, A. G., Smith, C. F., Claridge, T. D. W., Nicholson, B. D., Moreland, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2855 · Cited by 68
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
Dekker, Y., Dévédec, S. E. L., Danen, E. H. J., & Liu, Q. (2022) · Genes · doi:10.3390/genes13091585 · Cited by 66
Rinaldi, G., Rossi, M., & Fendt, S. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1397 · Cited by 65
Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
Wu, Z., Ma, H., Wang, L., Song, X., Zhang, J., Liu, W., Ge, Y., Sun, Y., Yu, X., Wang, Z., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0453-z · Cited by 63
Hsieh, Y.-C., Chen, Y.-M., Li, C.-Y., Chang, Y., Liang, S., Lin, S., Lin, C.-Y., Chang, S.-H., Wang, Y.-J., Khoo, K., et al. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.06.001 · Cited by 62
Chylomicrons stimulate incretin secretion in mouse and human cells
Psichas, A., Larraufie, P., Goldspink, D. A., Gribble, F. M., & Reimann, F. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4420-2 · Cited by 58
Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered
Kinlaw, W. B., Baures, P. W., Lupien, L. E., Davis, W. L., & Kuemmerle, N. B. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25332 · Cited by 59
Reaves, D. K., Ginsburg, E., Bang, J. J., & Fleming, J. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0411 · Cited by 61
Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating
Michalopoulou, E., Bulusu, V., & Kamphorst, J. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.256 · Cited by 59
Wang, C., Tong, Y., Wen, Y., Cai, J., Guo, H., Huang, L., Xu, M., Feng, M., Chen, X., Zhang, J., et al. (2018) · Hepatology · doi:10.1002/hep.30030 · Cited by 55
Aoki, T., Kinoshita, J., Munesue, S., Hamabe‐Horiike, T., Yamaguchi, T., Nakamura, Y., Okamoto, K., Moriyama, H., Nakamura, K., Harada, S., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12465-5 · Cited by 56
Bagwe‐Parab, S., Yadav, P., Kaur, G., Tuli, H. S., & Buttar, H. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01100 · Cited by 54
Torregrossa, L., Shintu, L., Chandran, J. N., Tintaru, A., Ugolini, C., Magalhães, A., Basolo, F., Miccoli, P., & Caldarelli, S. (2012) · Journal of Proteome Research · doi:10.1021/pr300105e · Cited by 53
Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles
Han, S., Mei, L., Quach, T., Porter, C. J. H., & Trevaskis, N. L. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03093-x · Cited by 54
McGowan, M. M., Eisenberg, B. L., Lewis, L. D., Froehlich, H. M., Wells, W. A., Eastman, A. R., Kuemmerle, N. B., Rosenkrantz, K. M., Barth, R. J., Schwartz, G. N., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2446-9 · Cited by 52
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
Chakraborty, P. K., Xiong, X., Mustafi, S. B., Saha, S., Dhanasekaran, D. N., Mandal, N. A., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2015) · Oncotarget · doi:10.18632/oncotarget.5424 · Cited by 51
LIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
Cadenas, C., Vosbeck, S., Edlund, K., Grgas, K., Madjar, K., Hellwig, B., Adawy, A., Glotzbach, A., Stewart, J. D., Lesjak, M. S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32138 · Cited by 56
Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment
Menard, J. A., Cerezo-Magaña, M., & Belting, M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0480 · Cited by 50
Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
Tiwary, S., Berzofsky, J. A., & Terabe, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02187 · Cited by 54
Prostate Cancer Progression: as a Matter of Fats
Scaglia, N., Frontini-López, Y. R., & Zadra, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719865 · Cited by 52
Mauldin, I. S., Wages, N. A., Stowman, A. M., Wang, E., Smolkin, M. E., Olson, W. C., Deacon, D. H., Smith, K. T., Galeassi, N., Chianese‐Bullock, K. A., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1881-y · Cited by 51
Diet and Pancreatic Cancer Prevention
Casari, I., & Falasca, M. (2015) · Cancers · doi:10.3390/cancers7040892 · Cited by 50
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma
Lu, J., Zhang, Y., Sun, M., Ding, C., Zhang, L., Kong, Y., Cai, M., Miccoli, P., Ma, C., & Yue, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737127 · Cited by 48
Ligorio, F., Pellegrini, I., Castagnoli, L., Vingiani, A., Lobefaro, R., Zattarin, E., Santamaria, M., Pupa, S. M., Pruneri, G., de Braud, F., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.023 · Cited by 49
Signaling Pathways Induced by Leptin during Epithelial–Mesenchymal Transition in Breast Cancer
Olea‐Flores, M., Juárez-Cruz, J. C., Catalán, M. A. M., Padilla‐Benavides, T., & Navarro‐Tito, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113493 · Cited by 48
Xiang, D., Zhang, K., Zeng, Y., Yan, Q.-Z., Shi, Z., Tuo, Q., Lin, L., Xia, B., Wu, P., & Liao, D.-F. (2020) · Medicine · doi:10.1097/md.0000000000018467 · Cited by 47
Lupien, L. E., Bloch, K. M., Dehairs, J., Traphagen, N. A., Feng, W. W., Davis, W. L., Dennis, T., Swinnen, J. V., Wells, W. A., Smits, N. C., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000327 · Cited by 46
Atypical plasma lipid profile in cancer patients: Cause or consequence?
Munir, R., Usman, H., Hasnain, S., Smans, K. A., Kalbacher, H., & Zaidi, N. (2014) · Biochimie · doi:10.1016/j.biochi.2014.03.010 · Cited by 45
Metadata
- Authors
- Kuemmerle, N. B., Rysman, E., Lombardo, P. S., Flanagan, A. J., Lipe, B. C., Wells, W. A., Pettus, J. R., Froehlich, H. M., Memoli, V. A., Morganelli, P. M., Swinnen, J. V., Timmerman, L. A., Chaychi, L., Fricano, C. J., Eisenberg, B. L., Coleman, W. B., & Kinlaw, W. B.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Kinlaw, William B.
- ORCID
- Venue
- Molecular Cancer Therapeutics
- Published
- 2011-03-01
- Volume
- 10
- Issue
- 3
- Pages
- 427-436
- ISSN
- 1535-7163 (ISSN-L)
- 1538-8514
- PMC
- PMC3074101
- OpenAlex
- W2117594441
- Cited by
- 286
- References
- 46
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 22 · 2023: 20 · 2022: 31 · 2021: 35 · 2020: 24 · 2019: 32 · 2018: 19 · 2017: 16 · 2016: 21 · 2015: 11 · 2014: 9 · 2013: 8 · 2012: 11
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Cancer Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Howard Hughes Medical Institute (52005870)
- Dartmouth College
- Fonds Wetenschappelijk Onderzoek
- Universität Ulm
- Vlaamse regering
- Norris Cotton Cancer Center
- National Cancer Institute (R01CA126618, P50CA058207, P30CA023108)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007508, DK 07508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- lipoprotein lipase, CD36, fatty acid uptake, dietary fat, solid tumor growth, lipolysis, triglyceride-rich lipoproteins, breast cancer, sarcoma, prostate cancer, fatty acid synthesis inhibition, cancer metabolism
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Female, Humans, Lipolysis, Lipoprotein Lipase, Liposarcoma, Male, Mice, Transgenic, Neoplasms, CD36 Antigens, Oligonucleotide Array Sequence Analysis, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Mice, Fatty Acid Synthesis Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review